Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Fate Therapeutics: Q4 Earnings Insights

Fate Therapeutics (NASDAQ:FATE) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
February 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Fate Therapeutics (NASDAQ:FATE) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Fate Therapeutics missed estimated earnings by 7.46%, reporting an EPS of $-0.72 versus an estimate of $-0.67.

Revenue was up $1.17 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.13 which was followed by a 2.97% increase in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Black Knight Earnings Preview

By Benzinga Insights
Today, 2:18 AM
Black Knight (NYSE:BKI) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that Black Knight will report an earnings per share (EPS) of $0.62.

BKI